Abstract: A composition containing Brilliant Blue G (BBG) or a pharmaceutically acceptable salt thereof, and a positional isomer of Brilliant Blue G (BBG) or a pharmaceutically acceptable salt thereof, the composition containing 90 wt % or more and 100 wt % or less of one or both of Brilliant Blue G (BBG) and the pharmaceutically acceptable salt thereof in the total of the Brilliant Blue G (BBG), the pharmaceutically acceptable salt of Brilliant Blue G (BBG), the positional isomer of Brilliant Blue G (BBG), and the pharmaceutically acceptable salt of the positional isomer of Brilliant Blue G (BBG), a method for producing said composition, and a method of removing the ocular membrane of a human patient.

Abstract: Disclosed herein is a composition comprising a pH-sensitive microcapsule comprising (1) a shell wall comprising at least one polymer chosen from cellulose derivatives and acrylate derivatives, and at least one structuring agent chosen from shellac, ethyl cellulose, and fumed silica, and (2) at least one functional ingredient encapsulated inside the shell wall; and a carrier having a pH of less than about 7. Further disclosed herein are methods of making a composition comprising a pH-sensitive microcapsule.

Abstract: The present invention relates to an oral composition and method for alleviating the symptoms associated with xerostomia using encapsulated cation-releasing compounds formulated either intimately together or in separate compartments in a composition containing cation-sensitive mucoadhesive polymers.

Abstract: Described herein are compositions comprising an unactivated liquid, an immobilized sparingly soluble acid or base, such that during storage the unactivated liquid is not in contact with the immobilized sparingly soluble acid or base, but upon use, the unactivated liquid contacts the immobilized sparingly soluble acid or base, whereby the pH of the liquid is altered, thereby activating the liquid to provide a benefit; together with variant and alternative designs, methods of making and using the compositions, and components thereof.

Abstract: Described herein are oral care compositions comprising an antibacterial agent and a dissolvable film comprising a pigment which provide a color change signal after a sufficient period of brushing, wherein the dentifrice base has water activity less than 0.78 and comprises anionic polymer in free or salt form 10-25% by weight of the dentifrice base, and anionic surfactant less than 3% by weight; together with methods of making and using the compositions.

Abstract: The present invention provides a glow in the dark staining agent for staining dental plaque includes a first plaque-disclosant comprising a fluorophore having an fluorescence emission after being exposed to a light source, wherein the fluorophore adheres to tooth plaque; and a second plaque-disclosant comprising a dye particle that adheres to tooth plaque and is visible.

Abstract: First, a coloured solution is claimed, comprising at least one perfluorocarbon as a solvent and a dye dissolved in the perfluorocarbon and selected from the family of fluorinated derivatives of phthalocyanines obtained by substituting one or more of the hydrogen H atoms linked to the benzene rings with a fluorine atom or a fluorinated group, for use in surgical methods for the treatment of the bodies of humans or animals, in particular in surgical methods of vitreoretinal surgery where the coloured solution acts as a retinal tamponade. Second, a coloured solution is claimed, comprising at least one perfluorocarbon selected from perfluorooctane, perfluorodecalin and perfluorophenanthrene as a solvent and a dye dissolved in the perfluorocarbon and selected from the family indicated above. The dye, in general, is preferably selected from the family of metalpoly(fluoroalkyl)phthalocyanines and even more preferably of metalpoly(perfluoroalkyl)phthalocyanines.

Abstract: The invention relates to a device (1) for the transplantation of cells (3) in suspension comprising a support with at least one micro-cavity (2) containing or able to contain said suspension in direct contact with the object on which the cells are to be transplanted. The device is intended for application to human tissue or human or animal body, such as the eye, the gingiva, skin, a wound or a burn.

Abstract: Described herein are dentifrices comprising a first formulation and a second formulation, wherein the formulations are coaxially extruded, so that the first formulation enrobes the second formulation, wherein the first formulation is opaque and wherein the second formulation comprises dissolvable film fragments, together with methods of making and using the same and containers for providing the same.

Abstract: Described herein are powder coated films comprising a polymer matrix designed for use in a children's toothpaste, compositions comprising the films; and methods of making and using the same.

Abstract: Described herein are compositions comprising a film, wherein the film comprises a pigment, and is adapted to release the pigment at a specific point in time during use; and methods of making and using the same.

Abstract: Oral care compositions and methods are described in which the composition includes a chalcone color change component, which may be phenyl-3-methoxy-4-hydroxystyryl ketone. The color change component is induced to change colors by addition of saliva and/or by a change in pH of the composition. The composition and methods provide benefits including providing visual cues to the user.

Abstract: The invention relates to a dye-containing preparation for use in ophthalmology and retinal surgery.

Abstract: The invention relates to personal care products containing multilayer films with decorative layers and may impart a noticeable color change. The invention is applicable in products including type toothpaste, soaps, and other products until diluted with water (or saliva).

Abstract: An eyelid margin wipe comprising chemical means for adjusting the temperature of the wipe relative to the ambient temperature. The wipe is particularly useful for treatment of disorders of the eyelid or eyelid margin such as meibomian gland dysfunction.

Abstract: The invention relates to a dye-containing preparation for use in ophthalmology and retinal surgery.

Abstract: A staining composition for staining an ophthalmic membrane when performing the ophthalmic membrane removal, wherein the staining composition comprises a Brilliant Blue G (BBG) derivative as a primary component.

Abstract: A composition is described herein comprising cyclosporin A, polysorbate 80, a polyoxyethylene stearate, and an oil; wherein the composition is an emulsion which is ophthalmically acceptable. Methods of treating diseases or conditions using said compositions, and medicaments related thereto, are also disclosed herein.

Abstract: A sustained-release matrix for dental application includes either an anti-microbial agent or a colorant that is released from the matrix when the matrix contacts water. The preferred matrices include a water-soluble polymer and a water-insoluble support resin.

Abstract: A pH sensitive chewing gum kit is provided. The kit may contain chewing gum incorporating a pH sensitive substance. When chewed, the gum may change it's color in response to the oral fluids or salivary pH level. The chewing gum kit may also contain chewing gum with or without artificial sweeteners and one or more pH sensitive members including at least one pH sensitive substance incorporated in at least one portion thereof. When a pH sensitive member is put in contact with oral fluids or saliva, before, during or after chewing the gum, the color of the pH sensitive substance may change to a color which depends on the oral fluids pH value. This color may indicate whether the gum still needs to be chewed in order to achieve a desired oral fluids pH level.